NCHR Testimony on Singulair and Neuropsychiatric Side Effects

September 27, 2019. Singulair has serious side effects and we need much better data to determine the likely benefit and risk of harm for patients. FDA has an important role to play in encouraging this research. In the meantime, patients, parents, and clinicians must be given clear information about the risks so that they can make an informed decision about whether to use montelukast (Singulair).

Read More »

NCHR Testimony on Non-Prescription Nicotine Mouth Spray

Nina Zeldes, National Center for Health Research, September 18, 2019 My name is Nina Zeldes and I am a Senior Fellow at the National Center for Health Research. Our research center analyzes scientific and medical data and provides objective health information to patients, providers and policy makers.  We do not accept funding from drug and medical […]

Read More »

NCHR Testimony on Peanut Allergen Powder for Children with Peanut Allergy

September 13, 2019. This is the first treatment for peanut allergies and if this drug is approved despite the unanswered questions, it will set a precedent for future drugs to treat food allergies. It is especially important that new classes of products provide strong evidence of safety and efficacy before approval, because it will be difficult if not impossible to obtain it afterwards.

Read More »